TMDX - CIK 0001756262
TransMedics Group, Inc. (TMDX) reported revenue of $605.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $605.49M | +37.1% |
| FY 2024 | $441.54M | +82.7% |
| FY 2023 | $241.62M | +158.5% |
| FY 2022 | $93.46M | +197.8% |
| FY 2021 | $31.39M | +10.7% |
| FY 2020 | $28.36M | +9.7% |
| FY 2019 | $25.84M | +98.5% |
| FY 2018 | $13.02M | - |
TransMedics Group, Inc. (TMDX) reported revenue of $605.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, TransMedics Group, Inc.'s revenue grew from $13.02M to $605.49M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.